Item 2.02 Results of Operations and Financial Condition.

On May 9, 2023, Spectrum Pharmaceuticals, Inc. issued a press release, which, among other matters, sets forth our results of operations for the quarter ended March 31, 2023. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

The foregoing information, including Exhibit 99.1, is being furnished under Item 2.02 and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.




(d) Exhibits.

Exhibit No.       Description

99.1                Press Release dated May 9, 2023

104               Cover Page Interactive Data File (embedded within the inline XBRL
                  document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses